Results 91 to 100 of about 78,921 (263)

Outcomes associated with azithromycin use among patients hospitalized with non-severe community-acquired pneumonia

Antimicrobial Stewardship & Healthcare Epidemiology
Introduction: Community-acquired pneumonia (CAP) is the leading infectious cause for hospitalization. Guidelines recommend use of a macrolide antibiotic with a beta-lactam for coverage of atypical organisms; however, data supporting macrolide coverage ...
Ashwin Gupta, Emily Walzl, David Ratz, Jennifer Horowitz, Elizabeth McLaughlin, Tejal Gandhi, Lindsay Petty, Anurag Malani, David Paje, Preeti Misra, Scott Kaatz, Steven Bernstein, Mariam Younas, Scott Flanders, Valerie Vaughn   +14 more
doaj   +1 more source

Biomaterials for Reconstructive Treatment of Peri‐Implantitis

Journal of Periodontal Research, EarlyView.
Reconstructive therapy should be implemented in contained defects. Various bone filler materials with or without a barrier membrane and/or adjunctive biologics may be applied. ABSTRACT Peri‐implantitis is a pathological condition affecting the tissues surrounding dental implants, marked by inflammation of the peri‐implant connective tissue and ...
Ausra Ramanauskaite, Anton Sculean, Emilio A. Cafferata, Frank Schwarz   +3 more
wiley   +1 more source

Review of Azithromycin Ophthalmic 1% Solution (AzaSite®) for the Treatment of Ocular Infections

, 2012
AzaSite® (azithromomycin 1.0%) ophthalmic solution was approved in 2007 by the US Food and Drug Administration (FDA) as the first commercially available formulation of ophthalmic azithromycin for the treatment of bacterial conjunctivitis.
Dominick L. Opitz, Jennifer S. Harthan
core   +1 more source

Platelet‐Rich Fibrins as Local Drug‐Delivery Carriers

Journal of Periodontal Research, EarlyView.
Autologous platelet concentrates (APCs), particularly platelet‐rich fibrin (PRF), act as biologically active fibrin scaffolds, capable of entrapping and gradually releasing therapeutic agents in oral and periodontal therapy. The incorporation of bioactive compounds, such as antibiotics, antifungals, vitamins, antidiabetic drugs, and exosomes, enhances ...
Karim M. Fawzy El‐Sayed, Christof E. Dörfer   +1 more
wiley   +1 more source

Genomic analysis of azithromycin-resistant Salmonella from food animals at slaughter and processing, and retail meats, 2011–2021, United States

Microbiology Spectrum
Azithromycin, a 15-membered ring macrolide, is among the recommended antimicrobials for treating invasive salmonellosis in humans. It is not approved for use in veterinary medicine. We analyzed the U.S. National Antimicrobial Resistance Monitoring System
Beilei Ge, Sampa Mukherjee, Cong Li, Lucas B. Harrison, Chih-Hao Hsu, Thu-Thuy Tran, Jean M. Whichard, Uday Dessai, Ruby Singh, Jeffrey M. Gilbert, Errol A. Strain, Patrick F. McDermott, Shaohua Zhao   +12 more
doaj   +1 more source

Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammation

Respiratory Research, 2017
Background Azithromycin, an antibiotic used for multiple infectious disorders, exhibits anti-inflammatory effects, but the molecular basis for this activity is not well characterized.
Elizabeth A. Lendermon, Tiffany A. Coon, Joseph S. Bednash, Nathaniel M. Weathington, John F. McDyer, Rama K. Mallampalli   +5 more
doaj   +1 more source

Etiology, pathogenesis and treatment of peri‐implantitis: A European perspective

Periodontology 2000, EarlyView.
Abstract Peri‐implantitis is a plaque‐associated pathological condition occurring in tissues around dental implants. It is characterized by inflammation in the peri‐implant mucosa and progressive loss of supporting bone. Over the last 30 years, peri‐implantitis has become a major disease burden in dentistry.
Tord Berglundh, Andrea Mombelli, Frank Schwarz, Jan Derks   +3 more
wiley   +1 more source

Clinical Effects of Traditional Chinese Medicine + Azithromycin in the Treatment of Mycoplasma Pneumonia

International Journal of General Medicine
Guan Zhang,1 Qian Li,2 Jing Zhang1 1Department of Infection, Taihe County Hospital of Traditional Chinese Medicine, Buyang City, Anhui Province, 236600, People’s Republic of China; 2Department of Pharmacy, Taihe County Hospital of Traditional Chinese ...
Zhang G, Li Q, Zhang J
doaj  

Longitudinal lung function trajectories in response to azithromycin therapy for chronic lung disease in children with HIV infection: a secondary analysis of the BREATHE trial

BMC Pulmonary Medicine
Background Chronic lung disease (CLD) is common among children with HIV (CWH) including in those taking antiretroviral therapy (ART). Azithromycin has both antimicrobial and anti-inflammatory effects and has been effective in improving lung function in a
Tafadzwa Madanhire, Grace McHugh, Victoria Simms, Lucky Ngwira, Carmen Gonzalez-Martinez, Robina Semphere, Brewster Moyo, Claire Calderwood, Mark Nicol, Tsitsi Bandason, Jon O. Odland, Andrea M. Rehman, Rashida A. Ferrand   +12 more
doaj   +1 more source

Mystery and misery of locally‐delivered drug therapy in periodontics. Historical concepts and current state

Periodontology 2000, EarlyView.
Abstract The primary objective is to critically analyze approaches to local therapy for periodontal disease, particularly in light of its well‐established systemic implications. We specifically address common misconceptions and overestimations regarding the potential of local treatments in contrast to their actual clinical effectiveness.
Andrea Mombelli, Alkisti Zekeridou
wiley   +1 more source